This inventor holds 18 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents, primarily in Biotechnology Research. Top assignees: Monsanto Company, Monsanto Technology LLC, Apt Therapeutics, Inc.. Active years: 1996-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chesterfield, MO (US) (1996 - 2000)
- Maryland Heights, MO (US) (1998 - 2011)
Company Filing History:

Years Active: 1996-2011
Areas of Expertise:
Title: The Innovative Contributions of Timothy A Mitsky
Introduction
Timothy A Mitsky is a notable inventor based in Maryland Heights, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of vascular disorders. With a total of 18 patents to his name, Mitsky's work has had a profound impact on medical treatments.
Latest Patents
Among his latest patents, Mitsky has developed innovative methods for the therapeutic use of ADPase enhanced apyrases. His inventions provide design and therapeutic applications of ADPase enhanced polypeptides, pharmaceutical compositions, and methods that are useful for preventing and reversing platelet aggregation and recruitment. These advancements are crucial for the treatment and prevention of vascular disorders in mammals.
Career Highlights
Mitsky has had a distinguished career, working with prominent companies such as Monsanto Company and Monsanto Technology LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.
Collaborations
Throughout his career, Mitsky has collaborated with esteemed colleagues, including Ganesh M Kishore and David M Stark. These partnerships have further enhanced his innovative capabilities and have led to the development of impactful inventions.
Conclusion
Timothy A Mitsky's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the treatment of vascular disorders, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile